Athena Diagnostics Sues Ambry Genetics over Diabetes Dx Tests | GenomeWeb

NEW YORK (GenomeWeb News) – Athena Diagnostics has sued Ambry Genetics for allegedly infringing four patents related to genetic tests for certain types of diabetes, according to court documents filed this week.

Athena, a Worcester, Mass.-based specialty brand of Thermo Fisher, filed four separate suits, with each suit claiming that Ambry infringes upon a different patent by selling genetic tests for maturity onset diabetes of the young, neonatal diabetes mellitus, and congenital hyperinsulinism.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.